Akoya Biosciences sees FY24 revenue $96M-104M, consensus $103.2M
PremiumThe FlyAkoya Biosciences sees FY24 revenue $96M-104M, consensus $103.2M
2M ago
Akoya Biosciences reports Q2 EPS (27c), consensus (27c)
Premium
The Fly
Akoya Biosciences reports Q2 EPS (27c), consensus (27c)
2M ago
AKYA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AKYA Upcoming Earnings Report: What to Expect?
2M ago
Akoya Biosciences price target lowered to $4 from $8 at Morgan Stanley
PremiumThe FlyAkoya Biosciences price target lowered to $4 from $8 at Morgan Stanley
4M ago
Akoya Biosciences price target lowered to $6 from $9 at BTIG
Premium
The Fly
Akoya Biosciences price target lowered to $6 from $9 at BTIG
4M ago
Canaccord cut Akoya target, sees buying opportunity on selloff
Premium
The Fly
Canaccord cut Akoya target, sees buying opportunity on selloff
4M ago
Akoya Biosciences reports Q1 EPS (48c), consensus (29c)
PremiumThe FlyAkoya Biosciences reports Q1 EPS (48c), consensus (29c)
4M ago
AKYA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
AKYA Earnings this Week: How Will it Perform?
4M ago
Akoya, NeraCare enter exclusive agreement for personalized therapy selection
Premium
The Fly
Akoya, NeraCare enter exclusive agreement for personalized therapy selection
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100